DAVID PENDARVIS - 03 Jan 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Administration Officer
Signature
David Pendarvis, Chief Administrative Officer
Issuer symbol
RMD
Transactions as of
03 Jan 2022
Net transactions value
-$399,155
Form type
4
Filing time
04 Jan 2022, 17:12:52 UTC
Previous filing
15 Dec 2021
Next filing
04 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale $399,155 -1,544 -1.3% $258.52 116,035 03 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.